Evaluates gene expression linked to epigenome variation in human cells, suggesting new insights for disease applications.
Background Understanding how epigenome variation contributes to gene expression in disease and development is a fundamental challenge. Regulatory regions show cell type-specific epigenome activity and differ in their location, size, and distance to their target genes, complicating discovery and analysis. Recent machine learning models have been proposed to address these problems by learning functions for the prediction of gene expression from epigenomic data. Results Here, we use the large IHEC EpiATLAS dataset to benchmark state-of-the-art linear and nonlinear approaches. We optimize each approach for over 28,000 human genes, providing an inferred regulatory catalog of gene models. In-depth comparison reveals that gene characteristics and the epigenomic complexity of the locus influence the difficulty of predicting the epigenome-to-transcriptome association. The model performance is further evaluated using CRISPRi and eQTL validation data. Based on these models, we conduct histone-acetylation association studies in a systematic way to investigate how epigenetic variation impacts gene expression. The model-based analysis revealed genes and regulatory regions linked to B-cell leukemia in patient data with known disease-related functions. Conclusions Our work provides a foundation for applications that link epigenome variation to gene expression in human cells, by benchmarking methods on a per-gene basis, illustrating their use in a disease context and making trained models available to the community.
No takes yet. Share an insight, caveat, or question.
Ardakani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: